Schiller L R, Davis G R, Santa Ana C A, Morawski S G, Fordtran J S
J Clin Invest. 1982 Nov;70(5):999-1008. doi: 10.1172/jci110711.
To determine whether the antidiarrheal action of opiate drugs in humans is due to enhanced intestinal absorption rates, as suggested by recent experiments in animals, or is due to altered intestinal motility, as traditionally thought, we studied the effect of therapeutic doses of codeine on experimental diarrhea and on the rate of intestinal absorption of water and electrolytes in normal human subjects. Our results show that codeine (30-60 mg i.m.) markedly reduced stool volume during experimental diarrhea induced by rapid intragastric infusion of a balanced electrolyte solution. There was, however, no evidence that codeine stimulated the rate of intestinal absorption in the gut as a whole or in any segment of the gastrointestinal tract, either in the basal state or when absorption rates were reduced by intravenous infusion of vasoactive intestinal polypeptide. We also measured segmental transit times to determine whether and where codeine delayed the passage of fluid through the intestine. Codeine caused a marked slowing of fluid movement through the jejunum, but had no effect on the movement of fluid through the ileum or colon. In other studies, we found that the opiate antagonist naloxone did not significantly affect water or electrolyte absorption rates in the jejunum or ileum. We conclude (a) that therapeutic doses of codeine increase net intestinal absorption (and thereby reduce stool volume) by increasing the contact time of luminal fluid with mucosal cells, not by increasing the rate of absorption by the mucosal cells; and (b) that endogenous opiates do not regulate intestinal absorption in humans.
为了确定阿片类药物在人体中的止泻作用是如近期动物实验所提示的那样,归因于肠道吸收速率的提高,还是如传统观点所认为的那样,是由于肠道运动的改变,我们研究了治疗剂量的可待因对正常人体实验性腹泻以及水和电解质肠道吸收速率的影响。我们的结果表明,可待因(30 - 60毫克,肌肉注射)在通过快速胃内输注平衡电解质溶液诱导的实验性腹泻期间显著减少了粪便量。然而,没有证据表明可待因在基础状态下或当通过静脉输注血管活性肠肽使吸收速率降低时,刺激了整个肠道或胃肠道任何节段的肠道吸收速率。我们还测量了节段转运时间,以确定可待因是否以及在何处延迟了液体在肠道中的通过。可待因使液体通过空肠的速度显著减慢,但对液体通过回肠或结肠的运动没有影响。在其他研究中,我们发现阿片类拮抗剂纳洛酮对空肠或回肠中的水或电解质吸收速率没有显著影响。我们得出结论:(a)治疗剂量的可待因通过增加肠腔液体与黏膜细胞的接触时间而非增加黏膜细胞的吸收速率来增加肠道净吸收(从而减少粪便量);(b)内源性阿片类物质在人体中不调节肠道吸收。